Oak (t7) IgE
Also known as: ImmunoCAP®
Use
This test quantifies an individual’s IgE response to oak. It is an in vitro quantitative assay, which is intended to be used in conjunction with other clinical information to aid in the diagnosis of allergic diseases. It may be preferred to skin testing in certain clinical situations such as widespread skin disease, recent use of antihistamines, uncooperative patients, or when skin testing poses a risk for serious allergic reaction. A definitive clinical diagnosis should not rely solely on this assay and must be evaluated by a trained healthcare professional considering all clinical and laboratory findings.
Special Instructions
Not provided.
Limitations
A definitive clinical diagnosis of allergy should not be based on the results of this single diagnostic method; it must be interpreted alongside clinical presentation and other findings. Allergen-specific serum IgE testing, while comparable to skin testing in many scenarios, may be influenced by false positives/negatives and requires clinical correlation.
Methodology
Immunoassay
Biomarkers
Oak (t7) IgE
Analyte
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.3 mL
Minimum Volume
0.15 mL
Container
Plastic screw‑cap vial
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant